Activation mechanism of phospholipase D involved in the generation of lipid mediators in cultured Madin-Darby canine kidney cells.
Addition of 100 nM phorbol 12-myristate 13-acetate (PMA), an active phorbol diester, to quiescent cultured Madin-Darby canine kidney (MDCK) cells caused a maximal stimulation of phosphatidylethanol formation within 1-2 h in the presence of 1% ethanol, indicating the activation of phospholipase D (PLD). The specificity of phorbol diesters for the activation of PLD activation was confirmed by the fact that phorbol 12,13-dibutyrate (PDBu) was effective, whereas 4 alpha-phorbol 12,13-didecanoate (4 alpha-PDD) was without effect. Down-regulation caused by the long-term pretreatment of the cells with active phorbol diesters significantly decreased the production of phosphatidylethanol. Staurosporine, a well known protein kinase (PK)C inhibitor at 1 microM, decreased the activation of PLD. Taken together, these observations suggested the involvement of PKC in the activation of PLD. The cellular PLD activity was found to be selectively localized in the particulate fraction by centrifugation at 12,000 x g. The particulate PLD showed the selective substrate specificity for phosphatidylcholine rather than phosphatidylethanolamine. In response to the addition of 100 nM PMA, 1,2-diacylglycerol (DG) increased in a biphasic fashion. In view of the time course of the activation of PLD, the second increase in the 1,2-DG around 20 min was contributed by the activation of PLD. In response to the simultaneous addition of 100 nM PMA and 100 nM A23187, the cultured MDCK cells activated the arachidonate cascades to form prostaglandin (PG)E2 and PGF2 alpha as major products, requiring slower 24 h to reach maximal levels.(ABSTRACT TRUNCATED AT 250 WORDS)
Yokota
K
K
Department of Bioresource Chemistry, Faculty of Agriculture, Shimane University, Japan.
Takeuchi
J
J
Jisaka
M
M
Takinami
K
K
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D002460:Cell Line; D002474:Cell-Free System; D002794:Choline / Q000378:metabolism; D003847:Deoxyglucose / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D004285:Dogs; D015777:Eicosanoids / Q000096:biosynthesis; D004789:Enzyme Activation / Q000187:drug effects; D004797:Enzyme-Linked Immunosorbent Assay; D007668:Kidney / Q000201:enzymology / Q000378:metabolism*; D050356:Lipid Metabolism; D019301:Oleic Acid; D009829:Oleic Acids / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D010739:Phospholipase D / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D001095:Arachidonic Acids; D015777:Eicosanoids; D009829:Oleic Acids; D010713:Phosphatidylcholines; D019301:Oleic Acid; D003847:Deoxyglucose; D010739:Phospholipase D; D015232:Dinoprostone; D002794:Choline; D013755:Tetradecanoylphorbol Acetate